Pharmerica Corp.

Pharmerica Corp. (PMC - Snapshot Report) shares have been advancing since originally being featured as a momentum stock in mid-July, climbing from $21 to just a pinch below $25, a solid short-term return of more than 15%.

Much of the recent price strength comes on the heels of this Zacks #1 rank stocks impressive second-quarter results, reported on Aug 8. Revenue skyrocketed to $486.3 million, up from $173.4 million in the same period last year. Net income surged to $2.9 million, a big jump from a loss of $400,000 last year. This produced earnings of 22 cents per share, ahead of analyst estimates of 19 cents per share.

Analysts are bullish on the Pharmerica's growth trajectory, with the next-year estimate pegged at $1.13 per share, up from $1.05 just 7 days ago. This would represent a 34% increase from the current-year year estimate of 84 cents. Take a look at the chart below.

Last Week's Momentum Zacks Rank Buy Stocks

Norfolk Southern Corp. (NSC - Snapshot Report) has been able to leverage its strong pricing power in order to grow its profits, as seen by the company's recently reported strong second-quarter results. Analyst estimates continue to advance, and this stock is once again pressuring its 52-week high. Read full Analysis.

ManTech International Corp. (MANT - Snapshot Report) has been able to maintain its growth trajectory in spite of the challenging economic environment. This government/defense consulting company recently reported strong quarterly results, provided a bullish earnings forecast and announced two big deals with two government agencies. Read full Analysis.

Strayer Education, Inc. (STRA - Analyst Report) has seen an up tick in its enrollment and revenue due to the weak economy, as many professionals head back to school to beef up their skills. The company's stock is trading with a very high P/E, but regardless, its share price continues to advance. Read full Analysis.

The Andersons Inc. (ANDE - Analyst Report) recently raised its full-year earnings guidance twice within a 30-day period, underscoring the strength of demand the company is experiencing in its plant nutrient segment. The Anderson's second-quarter results were great and its share price has been steadily advancing in response to the bullish environment. Read full Analysis.